Third Point Ventures
Third Point Ventures partners with innovative companies creating new products driven by new technologies. They bring deep technical expertise, a strong network of relationships, and extensive go-to-market experience to add value to their partners throughout their journey from idea to IPO and beyond. Their investment strategy is thematically driven, focusing on technology transitions that create market opportunities.
📥 Buy Full VC Dataset
Offices: Menlo Park (United States), New York (United States)
Investment Stages: Series A, Series B, Series C
Markets: Software, Cybersecurity, IT Infrastructure, Fintech, AI/ML, Data/AI/Analytics, DevOps, Healthcare, Consumer, Crypto, Media, Gaming and Metaverse, Mobility, Enterprise Applications, Industrial
Founded Year: 1995
Investor Type: Venture Capital, Hedge Fund
Portfolio Companies: Ahana, Akarna Therapeutics, Apigee, Aryaka, Atom Computing, Avedro, Balbix, Banyan Security, Bitwise, Bombas, C2FO, Cambridge Epigenetix, Catalytic Data Science, Ceptaris, Channel Medsystems, CipherTrace, Cloudvelox, Consensys, Dapper Labs, DataGrail, Didi, Elastica, Enigma, Enphase Energy, Epic Games, Equilibre Biopharmaceuticals, Field, FireHydrant, Formation Data Systems, Forter, Fulcrum Ception, Genvid Technologies, Global Locate, Grab, Grip Security, Healthtell, ICarbonX, Intelleflex, Intrexon, IQ Engines, Jane Technologies, Kentik, Kidozen, Kumu Networks, Litepoint, Lyft, N26, NextSilicon, Oryx Vision, Packet, Palantir, Prime Financial Technologies, PsiQuantum, R2 Semiconductor, Radia Communications, Rappi, Rivian, Rodin Therapeutics, Rubryc Therapeutics, SentinelOne, Sofi, Spline, Swift Capital, Sysdig, Trullion, Unravel, Upstart, Ushur, Ventyx Biosciences, Verbit, Wish, Xlumena, YellowBrick Data
Website: https://www.thirdpointventures.com
Team Page: https://www.thirdpointventures.com/team/
Portfolio Link: https://www.thirdpointventures.com/companies/
LinkedIn: https://www.linkedin.com/company/71879
Crunchbase: https://www.crunchbase.com/organization/third-point-ventures
Comments
No comments yet. Be the first to comment!